Does Faster Mean Better for Cancer Drugs? This Study Says No

May 9, 2018

The Food and Drug Administration (FDA) may be creating expectations among seriously ill patients that are unlikely to be fulfilled by designating new cancer drugs as breakthrough therapies, a Harvard Medical School faculty member told Bloomberg Law.